CIK 0001840233
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
Xilio Therapeutics, Inc.
Sign in to watch- Ticker
- XLO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851623397
- Phone
- +1 617-833-1027
- Business address
- 828 WINTER STREET, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-11 | Clancy Paul J Director | Grant or award · Stock Option (right to buy) | +31,000 | 31,000 | ||
| 2024-06-14 | Clancy Paul J Director | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2023-06-12 | Clancy Paul J Director | Grant or award · Stock Option (right to buy) | +13,200 | 13,200 | ||
| 2022-06-15 | Clancy Paul J Director | Grant or award · Stock Option (right to buy) | +13,200 | 13,200 | ||
| 2021-10-26 | Clancy Paul J Director | Grant or award · Stock Option (right to buy) | +44,033 | 44,033 | ||
| 2021-10-26 | Clancy Paul J Director | Grant or award · Stock Option (right to buy) | +65,528 | 65,528 |
Page 1 of 1 · 6 trades